(S)-2-((tert-Butoxycarbonyl)amino)-2-methylpent-4-enoic acid, 98%, 250mg

Botellas de oxígeno, de 100 a 150 ml, 14/23, 1 Pieza

5-(tert-Butyl) 2-ethyl 4-oxo-7,8-dihydro-4H-pyrazolo[1,5-a][1,4]diazepine-2,5(6H)-dicarboxylate, 98%, 1g

4-Nitro-3-(trifluoromethyl)benzaldehyde, 95.0%, 10g

(2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-methoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate, 97%, 10mg

Di(N-succinimidyl) Pimelate>98.0%(HPLC)(N)250mg

(R)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (2R,3R)-2,3-bis(benzoyloxy)succinate, 98%, 1g

2-(Methylthio)-4-(1H-pyrazol-4-yl)pyrimidine, 97%, 250mg

(S)-6-Bromo-2,3-dihydrobenzofuran-3-amine hydrochloride, 97%, 500mg

2-Benzylsulfanyl-4-chloro-6-diethoxymethyl-pyrimidine, 95.0%, 250mg

4'-Bromoacetophenone, 99.0%, 100g

Ethyl 5-Bromo-2-iodobenzoate, 95.0%, 5g

Fosfato de hidrógeno disódico 12 H2O, mínimo 98,5 %, Ph.Eur., 25 kg, envase de plástico.